SCHEMBL8784256

SCHEMBL8784256

CC(c1ccc2[nH]cc(CCN(C)C)c2c1)c1nc[nH]n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 12/20 0.66
HTR1B P28222 9/20 0.66
HTR1A P08908 8/20 0.53
HTR2C P28335 4/20 0.53
HTR2A P28223 3/20 0.53
HTR3E A5X5Y0 2/20 0.53
HTR3B O95264 2/20 0.53
HTR1E P28566 2/20 0.53
HTR1F P30939 2/20 0.53
HTR7 P34969 2/20 0.53
HTR2B P41595 2/20 0.53
HTR3A P46098 2/20 0.53
HTR5A P47898 2/20 0.53
HTR6 P50406 2/20 0.53
HTR4 Q13639 2/20 0.53
HTR3D Q70Z44 2/20 0.53
HTR3C Q8WXA8 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8783766 0.80 HTR1D (0.66) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL8783853 0.78 HTR1D (0.67) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL5295276 0.76 HTR1D (0.72) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL8783635 0.76 HTR1D (0.60) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL5752140 0.75 HTR1A (0.71) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL7809973 0.74 HTR1D (0.72) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL8113315 0.74 HTR1D (0.64) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL8112396 0.73 HTR1D (0.60) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL8784129 0.72 HTR1D (0.61) HTR1DHTR1BHTR1AHTR2CHTR2A
SCHEMBL9688472 0.71 HTR1D (0.67) HTR1DHTR1BHTR1AHTR2CHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497512-B1 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME (GB) 1997-09-24 EP claimed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 EP claimed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 EP claimed
EP-0497512-B1 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME (GB) 1997-09-24 EP disclosed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 EP disclosed
US-5602163-A SELECTIVE AGONISTS OF 5-HYDROXYTRYPTAMINE RECEPTORS; USEFUL IN TREATMENT OF MIGRAINE HEADACHES MERCK, SHARP & DOHME LTD. (GB) 1997-02-11 US disclosed
US-5602162-A TREATMENT AND/OR PREVENTION OF MIGRAINE MERCK, SHARP & DOHME LTD. (GB) 1997-02-11 US disclosed
US-5451588-A Treatment of migraines MERCK SHARP & DOHME LTD. (GB) 1995-09-19 US disclosed
US-5298520-A Triazole containing indole derivatives MERCK SHARP & DOHME LIMITED (GB) 1994-03-29 US disclosed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 EP disclosed